Show simple item record

dc.contributor.authorMoran, Ken_US
dc.contributor.authorPriebe, Sen_US
dc.date.accessioned2016-02-23T15:15:09Z
dc.date.available2016-01-26en_US
dc.date.issued2016-08en_US
dc.date.submitted2016-01-28T15:12:22.963Z
dc.identifier.issn0962-9343en_US
dc.identifier.otherQURE-D-15-00395R4
dc.identifier.otherQURE-D-15-00395R4
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11233
dc.description.sponsorshipThis trial was funded by the National Institute of Health Research Health Technology Assessment (Project No. 07/60/43)en_US
dc.format.extent1897 - 1902en_US
dc.relation.ispartofQUALITY OF LIFE RESEARCHen_US
dc.rights• “The final publication is available at Springer via http://link.springer.com/article/10.1007/s11136-016-1238-1/fulltext.html#copyrightInformation”
dc.subjectFinancial incentivesen_US
dc.subjectSchizophreniaen_US
dc.subjectPsychosisen_US
dc.subjectQuality of lifeen_US
dc.subjectAdherenceen_US
dc.subjectAnti-psychoticen_US
dc.titleBetter quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?en_US
dc.typeArticle
dc.identifier.doi10.1007/s11136-016-1238-1en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380005900003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue8en_US
pubs.notes6 monthsen_US
pubs.publication-statusPublisheden_US
pubs.volume25en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record